Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion type Assertion NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_head.
- NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_provenance.
- NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion evidence source_evidence_literature NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_provenance.
- NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion SIO_000772 25135868 NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_provenance.
- NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion wasDerivedFrom befree-2016 NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_provenance.
- NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion wasGeneratedBy ECO_0000203 NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_provenance.